Over the past decade, Malaysia has earned a reputation as a safe and reliable destination for healthcare travelers from different walks of life and of all ages.
Healthcare Malaysia has demonstrated an unprecedented commitment to improving the health of healthcare travelers through its world-class quality healthcare and easily accessible and relatively affordable service offerings for peace of mind. of the patient.
Malaysia has become an increasingly preferred destination for healthcare travelers seeking medical treatment related to fertility, cardiology, oncology and hepatitis C, thanks to the experienced medical experts, to the availability of cutting-edge technology and high-quality treatment options with good clinical outcomes and the overall and seamless end-to-end patient experience offered.
Fertility Hub of Asia: Bringing Hope to Dreams
As Asia’s fertility hub, Malaysia is an increasingly preferred healthcare destination for fertility treatments, recording 67% revenue growth between 2015 and 2019 in the Chinese market alone, healthcare travel contributing to the total at 125% per year. – Annual revenue growth from 2017 to 2018.
With the availability of advanced treatments such as AI technology for fertility viability testing, fertility facilities in Malaysia are reporting high success rates such as 82.9% through single blastocyst transfer good quality euploid and 68% in embryo transfers for women over 41 years old. age with the source of preimplantation genetic testing (PGT).
Additionally, out of 30 fertility centers worldwide that have international RTAC accreditation, eight are in Malaysia.
Fertility treatments in Malaysia are also reasonably priced at USD 4,000-5,000 per cycle. Patients seeking healthcare in Malaysia will benefit from a holistic and seamless end-to-end travel experience, where they can expect to receive top quality care at every stage of their journey, from pre to post- processing.
Asia Heart Center
Malaysia’s history in cardiology begins in the 1960s, marking the beginning of cardiothoracic surgery services in Malaysia. Soon after, the National Heart Association of Malaysia was formed to further expand the country’s expertise in cardiovascular disease through education, research and health care policies.
In the early 1990s, cardiac care became available in private health facilities, with the National Institute of Cardiology (IJN) advancing with world-class breakthroughs in cardiac care. Since its inception in 1992, the IJN has treated more than four million patients from various countries around the world.
With an abundance of world-class hospitals with solid reputations in cardiac care, coupled with the best medical expertise, technologies and personnel, Malaysia is positioning itself as the heart center of Asia, where healthcare travelers can access world-class quality cardiac care at competitive prices.
Malaysia is also home to the first hospital outside the United States to implant the Micra AV Pacemaker, an implantable device for the treatment of slow heartbeat through pacing.
The country is also the first in the Asia-Pacific region to successfully perform a bio-absorbable (PV) pulmonary valve conduit implant on three children with congenital heart defects (the fifth, sixth and seventh patients worldwide to undergo this surgery).
Cancer Center of Excellence
In addition to being recognized as the heart and fertility centers of Asia, Malaysia is also gaining an international reputation as a Cancer Care Center of Excellence (Cancer COE), becoming the third most prepared country of the Asia-Pacific region in the fight against cancer, according to a study conducted by The Economist‘s Economist Intelligence Unit (EIU).
Malaysia is home to 128 medical and clinical oncologists from the public and private sectors, who are fully equipped to meet patient demands.
Of the 79 member hospitals of the MHTC, more than 30 hospitals focus on multiple types of cancer, including breast, lung, nasopharyngeal, colorectal, and lymphoma.
In addition, cancer treatments in Malaysia also focus heavily on palliative care for terminal cancer and rehabilitation of cancer survivors. It has access to the latest medical drugs that are not readily available in other parts of Southeast Asia, while keeping the cost of treatment affordable.
Asia Hepatitis C Treatment Center
In response to the World Health Organization (WHO) mission to reduce new viral hepatitis infections by 90% by 2030, Malaysia is leading the way as a treatment hub for hepatitis C in Asia, providing accessible, affordable and effective treatment options.
Hepatitis C is known as a silent disease and has affected approximately 58 million people worldwide. Many are unaware of this condition, its symptoms, and the lack of access to necessary treatment solutions.
If left untreated, hepatitis C can lead to chronic diseases such as liver cirrhosis and liver cancer. As such, it is important to test, treat, and cure by taking preventative care through top quality health care screenings.
Malaysia opened its borders on April 1, 2022 and we look forward to the day when borders around the world will also be fully reopened.
The country is ready to welcome healthcare travelers seeking medical care in a safe and reliable destination. Click on here for more information.
Mohd Daud Mohd Arif is the CEO of Malaysia Healthcare Travel Council (MHTC).
- This is the personal opinion of the author or publication and does not necessarily represent the views of code blue.